Teleflex (NYSE:TFX) Updates FY 2026 Earnings Guidance

Teleflex (NYSE:TFX) issued an update on its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 6.900-7.200 for the period, compared to the consensus earnings per share estimate of 6.700. The company issued revenue guidance of $2.3 billion-$2.3 billion, compared to the consensus revenue estimate of $2.3 billion.

Analyst Ratings Changes

TFX has been the topic of a number of recent analyst reports. BMO Capital Markets initiated coverage on Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target on the stock. Raymond James Financial restated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $140.00 to $160.00 in a research report on Monday, June 8th. Truist Financial reissued a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Finally, Needham & Company LLC lifted their price target on Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $148.90.

Teleflex Price Performance

Shares of TFX stock traded up $2.83 during mid-day trading on Thursday, hitting $139.61. 1,301,231 shares of the stock were exchanged, compared to its average volume of 482,291. Teleflex has a 52-week low of $100.18 and a 52-week high of $145.00. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The company has a market cap of $6.18 billion, a PE ratio of -6.12, a price-to-earnings-growth ratio of 1.02 and a beta of 0.81. The firm has a fifty day moving average of $131.61 and a 200 day moving average of $122.46.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.Teleflex’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Research analysts anticipate that Teleflex will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be given a $0.34 dividend. The ex-dividend date is Friday, August 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s payout ratio is -5.96%.

Key Headlines Impacting Teleflex

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Quarterly results exceeded expectations. Teleflex reported second-quarter adjusted EPS of $1.76, topping the $1.28 consensus estimate, while revenue of $570.3 million surpassed expectations of $559.6 million. Revenue rose 28.9% year over year, providing the main catalyst for the stock’s upward move. Teleflex Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Full-year earnings guidance was raised above analyst expectations. Teleflex forecast fiscal 2026 EPS of $6.90 to $7.20, compared with the $6.70 consensus estimate. Revenue guidance of approximately $2.3 billion was broadly in line with expectations, suggesting the earnings upside is being driven primarily by profitability and execution. Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
• Positive Sentiment: Teleflex declared a quarterly dividend. Shareholders of record on August 14 will receive $0.34 per share on September 30. The dividend provides an annualized payout of approximately $1.36 per share and a yield of about 1%, adding modest shareholder-return support.
• Neutral Sentiment: Profitability remains mixed. GAAP diluted EPS from continuing operations was $0.96, down from $1.54 a year earlier, and the company reported a negative net margin. The adjusted EPS beat and higher outlook outweighed these concerns for investors, but the year-over-year decline remains a risk to monitor. Teleflex Posts Strong Q2 2026 Results

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC lifted its stake in shares of Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after buying an additional 1,956,811 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in Teleflex by 123.9% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock valued at $80,855,000 after acquiring an additional 365,663 shares in the last quarter. Gumshoe Capital Management LLC purchased a new stake in Teleflex during the 4th quarter valued at about $31,432,000. Integral Health Asset Management LLC acquired a new stake in Teleflex in the 4th quarter valued at about $30,510,000. Finally, Walleye Capital LLC raised its holdings in Teleflex by 270.8% in the 4th quarter. Walleye Capital LLC now owns 319,168 shares of the medical technology company’s stock valued at $38,951,000 after acquiring an additional 233,102 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.